In response to the crisis caused by COVID-19, Eli Lilly and Company has introduced the Lilly Insulin Value Program, allowing anyone with commercial insurance and those without insurance at all to fill their monthly prescription of Lilly insulin for $35.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.